DOWNLOAD

 DATA SHEET
Lapigen-50 Gentamicin Injectable Solution Kind Antibiotic Formulation Injectable Presentations LIVESTOCK: Flask with 250 mL Registry REG. SAGARPA Q -2083- 042
  • FORMULA
     INGREDIENTS: Guaranteed analysis Gentamicin base (such as Gentamycin sulfate) 50 mg vehicle cbp 1 mL INERT INGREDIENTS Inert ingredients up to 100%
  • DESCRIPTION
     INDICATIONS: Broad spectrum antibiotic indicated in the treatment of diseases caused by Gram negative and Gram positive bovine, swine and equine. For the treatment of bacterial infections of the respiratory, gastrointestinal and genitourinary tracts and mastitis. It is used usually associated with penicillin, amoxicillin or ampicillin for digestive pictures and / or lung, urinary tract infections, bone and joint infections.
  • DOSE
    ADMINISTRATION: Deep Intramuscular. Respiratory infections and sepsis: 5 mg / kg / day intramuscularly 3 to 5 days. Intestinal infections and genitourinary: 4 mg / kg / day intramuscularly 3 to 5 days. CERVICITIS, METRITIS, ENDOMETRITIS IN COWS: 200 mg to 1000 mg diluted in physiological saline. Intrauterine application. SWINE: Prevention and treatment of colibacillosis and intestinal infections, inject 5 mg intramuscularly pig as a single dose for 3 consecutive days. POULTRY: Prevention of premature mortality in chickens one day old caused by E. coli, E. aerogenes, P. aeruginosa and Salmonella. Mares metritis, cervicitis and endometritis: use by intrauterine route of 500 mg to 2500 mg daily for 3 to 5 days during mating season when the cervix is relaxed.
  • WARNINGS
    Do not use this product 60 days before slaughter of animals intended for human consumption. Not used for human consumption milk from animals treated with this product, until 4 days after the last application. Do not use in pregnant animals. Do not apply in cases of renal insufficiency or after prolonged treatment with other aminoglycosides. Do not use in conjunction with diuretics. Store in a cool, dry place, protected from light.

All rights reserved Lapisa 2018 © | Notice of Privacy